D
r.
Phillippe Michel
Country
France
Job title
Medical director
Organisation
CCECQA
Comité de Coordination de l'Evaluation Clinique
et de la Qualité en Aquitaine
Email address
Website
Biography
Mr Michel has been Medical Director of the CCECQA since 1996 (www.ccecqa.asso.fr).
In France, he was in charge of the 2004 French national survey on adverse events.
He has been a member of the WHO World Alliance for Patient Safety from its start in November 2003; he is currently one of the five members of the steering group of its 4th action area “Research in Patient safety”.
He is a member of the cross-research council network in patient safety research (Dr. Richard Lilford, UK).
Mr Michel is a medical doctor. He holds a master in Health Economics and a PhD in Epidemiology and biostatistics. He published more than fifty articles in indexed journals, about twenty articles in other journals and edited several books
Description organisation
The CCECQA (committee for co-ordinating clinical Evaluation and Quality in Aquitaine) was created in 1996 by the medical and administrative authorities of the Aquitaine region. It has over 60 funding members (hospitals representing 16000 beds, 96% of the total public beds and 40% of the private beds). In coordination with the national and regional authorities, he is in charge of developing quality improvement and risk management projects for its members. Five action areas are implementation of risk management in the clinical activities, development of clinical audit and other improvement activities in patient care, implementation of quality and safety indicators, mobilisation and empowerment of patient and consumer associations in the healthcare system, and help to hospitals for meeting the accreditation requirements
ONELINER
patient safety
Publications
patient safety
Michel P, Quenon JL, deSarasqueta AM, Scemama O. Comparison of three methods for estimating rates of adverse events and rates of preventable adverse events in acute care hospitals. BMJ 2004;328(7433):199-202.
Michel P. Management of patient safety in French hospitals. Rev Calidad Asistencial 2004;19(extraordin 1):9-10.
Michel P. Strengths and weaknesses of available methodologies for assessing the nature and scale of harm caused by the health system (review). Genève: World Health Organisation; 2005: in press.
Quenon JL, Michel P, de Sarasqueta AM. Leçons pour la sécurité des soins: tirer les leçons des expériences du passé. Risques et Qualité 2005;2(1):50-2.
Michel P, Quenon JL, Djihoud A, Tricaud-Vialle S, de Sarasqueta AM, Domecq S. Les événements indésirables graves liés aux soins dans les établissements de santé : premiers résultats d'une étude nationale. Etudes et Résultats 2005;n°398.
Michel P, Domecq S, Castot A, Caron J, Dufay E, Queneau P, et al. Multiprofessional review of adverse drug events (ADE) from the French national adverse event survey (ENEIS) (P143). Fundam Clin Pharmacol 2005;19:230.
Michel P, Aranaz JM, Limón R, Requena J. Siguiendo la pista de los efectos adversos: Cómo detectarlos. Rev Calidad Asistencial 2005;20(4):204-10.
Michel P, Billiard-Decré C, Daucourt V, Domecq S, Piscarel M, Pourin C, et al. Structures régionales d'évaluation, de démarche qualité et de gestion des risques pour les établissements de santé : exemple du CCECQA et facteurs clés de succès. Gestions Hospitalières 2004;12:804-808.
Adjeoda K, Michel P, de Sarasqueta AM, Pohié E, Quenon JL. Analyse approfondie des causes d'évènements iatrogènes en milieu hospitalier : étude de la reproductibilité des analyses réalisées dans l'étude ENEIS. Risques et Qualité 2004(4):9-15.